Author: Secura Bio

Secura Bio Announces Two Duvelisib Presentations on Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma at the 2026 American Society of Hematology Annual Meeting

November 4, 2026
Secura Bio Expands Chief Financial Officer Will Brown’s Leadership Role to Include Chief Operating Officer

February 19, 2026

Secura Bio Announces Two Duvelisib Presentations on Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma at the 2026 American Society of Hematology Annual Meeting